NEW YORK (GenomeWeb News) – Illumina has named Joel McComb senior VP and GM of Life Sciences, and Gregory Heath as senior VP and GM of the company’s Diagnostics Business unit.
 
McComb was president of Interventional Medicine at GE Healthcare, and he formerly was president and CEO of Innovadyne Technologies. He also was GM of Primary Care Diagnostics and director of corporate business development at Beckman Coulter.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.